This page lists all pharmaceutical reports related to the field of GenitoUrinary Tract Disorders. The reports include market research reports and pipeline analyses.
- Mens Health: The Market for Current and Emerging Drug Therapies
- Nitric Oxide - Therapeutics, Markets and Companies
- Urinary Tract Agents Annual Report 2005
- Early Toxicology: Markets and Approaches
- Erectile Dysfunction - Product differentiation and patient segmentation
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- From Blockbuster to Nichebuster
- Dry Overactive Bladder - A Precursor to 'Wet Overactive Bladder'?
- Interstitial Cystitis - Few Treatments, Poor Outcome
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Biogenerics
- Major Milestones: Female Sexual Dysfunction
- Urinary Incontinence: Major Milestones
- HRT: Major Milestones - Current Perspectives on HRT and Menopause
- Palatin Technologies' Bremelanotide - Competition and regulatory risk cloud potential
- Indevus Pharmaceuticals’ Sanctura XR - Last-to-market entrant unlikely to make an impact
- Management of Urinary Incontinence and Overactive Bladder - A Global Overview
- Mixed Urinary Incontinence - An Opportunity for Novel Drug Therapies
- Stress Urinary Incontinence - Opinion Divided on Drug Therapy
- Urge Urinary Incontinence - Poor Differentiation Limiting New Product Uptake
- Urinary Incontinence and Overactive Bladder - The Perspective of the Continence Nurse in the US
- Female Sexual Dysfunction - 2005 physician survey
- Drug Discovery Tools for High-Content Analysis
- The Women’s Health Market Outlook to 2011
- Female Sexual Dysfunction: Prescription Drug Pipeline Overview 2007
- URINARY TRACT INFECTIONS - Therapy Area Pipeline Report
- VAGINAL INFECTIONS - Therapy Area Pipeline Report
- Infertility - Therapy Area Pipeline Report
- MENOPAUSAL SYMPTOMS - Therapy Area Pipeline Report
- FEMALE SEXUAL DYSFUNCTION - Therapy Area Pipeline Report
- ENDOMETRIOSIS - Therapy Area Pipeline Report
- CONTRACEPTION - Therapy Area Pipeline Report
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
- Commercial and Pipeline Insight: Infertility
- Biosimilars Series: Strategic issues - Potential remains uncertain
- Translational Medicine in Biopharmaceutical Research and Development
- Licensing Strategies - Current Pharmaceutical Licensing Trends
- Stakeholder Opinions: Endometriosis - Scientific clarity will unlock market potential
- Urinary Incontinence: Market Update - Growing Market Brings Opportunities for New Drugs
- Pipeline Insight: Endometriosis - Growing the Patient Population is Key to Unlocking the Market's Co
- The Lifestyle Drugs Outlook to 2008: Unlocking new value in well-being
- The Women's Health Outlook to 2008: Market and pipeline analysis of major female disorders
- Commercial Opportunities from an Aging Population: Epidemiology, market and pipeline analysis across seven major indications
- Women's Health: Worldwide Prescription Drug Markets - 3rd Edition
- Men's Health: The World Market for Current and Emerging Drug Therapies
- Gene Expression Profiling Markets
- The Pharmaceutical Company Outlook to 2012: Strategic Analysis of Sales Outlook for Big Pharma
- Lifestyle Drugs Market Outlook: Key Indications, Epidemiology, and Emergent Drugs
- How to Conduct Clinical Trials in China
- Erectile Dysfunction Market Assessment & Analysis 2007-2022
- Pipeline and Commercial Insight: Urinary Incontinence - Lifecycle management strategies
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
- The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players